• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    NuCana plc - American Depositary Shares (NQ:NCNA)

    1.870 -0.080 (-4.10%)
    Streaming Delayed Price Updated: 9:45 AM EDT, Jun 11, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about NuCana plc - American Depositary Shares

    < Previous 1 2 Next >
    News headline image
    NuCana Appoints Ian Webster as Chief Financial Officer
    From NuCana plc
    Via GlobeNewswire
    News headline image
    NuCana Reports First Quarter 2026 Financial Results and Provides Business Update
    From NuCana plc
    Via GlobeNewswire
    News headline image
    NuCana Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Business Update
    From NuCana plc
    Via GlobeNewswire
    News headline image
    NuCana Appoints Theresa Bruce as Chief Operating Officer
    From NuCana plc
    Via GlobeNewswire
    News headline image
    NuCana Presents Latest Data Demonstrating Clinical Activity and Favorable Safety for NUC-7738 in Patients with PD-1-Resistant Melanoma
    Data Presented at ESMO IO 2025 include Partial Responses, Durable Disease Control, and No New Safety Signals, Reinforcing Earlier Findings 
    From NuCana plc
    Via GlobeNewswire
    News headline image
    NuCana Reports Third Quarter 2025 Financial Results and Provides Business Update
    From NuCana plc
    Via GlobeNewswire
    News headline image
    NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in China
    From NuCana plc
    Via GlobeNewswire
    News headline image
    NuCana Presents Encouraging Data on NUC-7738 in Combination with PD-1 Inhibitors using Primary Patient-Derived Organoids and Autologous Tumor-Infiltrating Lymphocytes at the ESMO Congress 2025
    From NuCana plc
    Via GlobeNewswire
    News headline image
    NuCana Announces Encouraging Data for NUC-3373 in Combination with Anti-PD-1 Therapy
    From NuCana plc
    Via GlobeNewswire
    News headline image
    NuCana Compliant with All Nasdaq Continued Listing Criteria
    Anticipated Cash Runway into 2029 
    From NuCana plc
    Via GlobeNewswire
    News headline image
    NuCana to Present Data on NUC-7738’s Synergy with PD-1 Inhibitors at the ESMO Congress 2025
    From NuCana plc
    Via GlobeNewswire
    News headline image
    NuCana Reports Second Quarter 2025 Financial Results and Provides Business Update
    From NuCana plc
    Via GlobeNewswire
    News headline image
    NuCana Announces ADS Ratio Change
    From NuCana plc
    Via GlobeNewswire
    News headline image
    Element79 Gold Corp Shifts Focus to US Projects and Appoints New VP of Corporate Development – More Stocks Inside
    Via AB Newswire
    News headline image
    NuCana Cancels All Outstanding Series A Warrants Following Strategic ATM Execution
    From NuCana plc
    Via GlobeNewswire
    News headline image
    Micro-Cap Surge: NCNA, HCTI, SPZI, PNPN.V in MedTech, AI, Healthcare, Energy, Metals, Minerals, Etc. – More Stocks Inside
    Via AB Newswire
    Topics Artificial Intelligence
    News headline image
    NuCana Announces Plan to Implement ADS Ratio Change
    From NuCana plc
    Via GlobeNewswire
    News headline image
    Clifton Mining (OTC: CFTN) Ramps Up Mining Operations – More Stocks Inside
    Via AB Newswire
    News headline image
    NuCana Reports First Quarter 2025 Financial Results and Provides Business Update
    From NuCana plc
    Via GlobeNewswire
    News headline image
    Pennies on the Rise: HCTI, SWISF, ADHC, NCNA Gain Traction Amid LargeCap Uncertainty – More Stocks Inside
    Via AB Newswire
    News headline image
    NuCana Prices $7 Million Registered Direct Offering
    From NuCana plc
    Via GlobeNewswire
    News headline image
    Stocks Under $1 To Watch: $NITO, $SPRC, $PNPNF, $NCNA, $PRSO – Multi-Sectors Momentum Building more inside…
    Via AB Newswire
    Topics Intellectual Property
    News headline image
    NuCana Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update
    From NuCana plc
    Via GlobeNewswire
    News headline image
    NuCana Reports Third Quarter 2024 Financial Results and Provides Business Update
    From NuCana plc
    Via GlobeNewswire
    News headline image
    NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel
    From NuCana plc
    Via GlobeNewswire
    News headline image
    NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States
    From NuCana plc
    Via GlobeNewswire
    News headline image
    NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024
    Combination of NUC-7738 plus Pembrolizumab Resulted in Prolonged Progression Free Survival, a Compelling Disease Control Rate including Partial Responses, and a Favorable Safety Profile 
    From NuCana plc
    Via GlobeNewswire
    News headline image
    NuCana Announces Update for Phase 2 Randomized Colorectal Cancer Study
    From NuCana plc
    Via GlobeNewswire
    News headline image
    NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update
    From NuCana plc
    Via GlobeNewswire
    News headline image
    NuCana to Present at the Jefferies Global Healthcare Conference
    From NuCana plc
    Via GlobeNewswire
    < Previous 1 2 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.